Invention Application
US20140161736A1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
有权
具有肌钙蛋白受体拮抗剂和BETA2 ADRENERGIC受体激动剂的化合物
- Patent Title: COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
- Patent Title (中): 具有肌钙蛋白受体拮抗剂和BETA2 ADRENERGIC受体激动剂的化合物
-
Application No.: US14098735Application Date: 2013-12-06
-
Publication No.: US20140161736A1Publication Date: 2014-06-12
- Inventor: Fabio Rancati , Ian Linney
- Applicant: CHIESI FARMACEUTICI S.p.A
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.p.A
- Current Assignee: CHIESI FARMACEUTICI S.p.A
- Current Assignee Address: IT Parma
- Priority: EP12195891.2 20121206
- Main IPC: A61K31/439
- IPC: A61K31/439 ; A61M16/14 ; A61M15/00 ; C07D453/02 ; A61K45/06
Abstract:
Compounds of formula (I) described herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.
Public/Granted literature
- US08987299B2 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Public/Granted day:2015-03-24
Information query
IPC分类:
